34 participants
Cabozantinib Dose Skipping as an Alternative to Dose Reductions
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-31
- Start Date:
- 2026-01-26
- Completion:
- 2027-09-01
Conditions
- Renal Cell Carcinoma (RCC)
Interventions
- DRUG
No Results Yet